Celyad Oncology S.A.

CLYYF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$4,200$7,004$12,445$30,018
Short-Term Investments$0$0$0$0
Receivables$908$380$1,259$2,340
Inventory$417$1,260$0$0
Other Curr. Assets$990$2,477$1,121$1,934
Total Curr. Assets$6,515$11,121$14,825$34,292
Property Plant & Equip (Net)$1,493$1,830$309$3,248
Goodwill$0$342$0$883
Intangibles$405$48$864$35,285
Long-Term Investments$1,420$2,804$0$2,209
Tax Assets$0$0$0-$2,209
Other NC Assets$95$137$3,718$6,235
Total NC Assets$3,413$5,161$4,891$45,651
Other Assets$0$0$0$0
Total Assets$9,928$16,282$19,716$79,943
Liabilities
Payables$1,233$1,243$4,752$6,611
Short-Term Debt$284$156$274$1,804
Tax Payable$0$0$0$0
Deferred Revenue$785$0$1,326$1,458
Other Curr. Liab.$544$1,533$4,074$3,954
Total Curr. Liab.$2,846$2,932$10,426$13,827
LT Debt$17,394$902$118-$13,002
Deferred Rev, NC$4,291$4,576$4,584$5,851
Deferred Tax Liab, NC$0$0$0$14,732
Other NC Liab.$1,517$1,568$271$14,896
Total NC Liab.$23,202$23,677$4,973$22,477
Other Liabilities$0-$16,631$0$0
Cap. Leases$905$1,058$255$2,632
Total Liabilities$26,048$9,978$15,399$36,304
Equity
Pref Stock$0$0$0$0
Common Stock$8,216$32,949$78,585$78,585
Retained Earnings-$364,196-$358,372-$349,947-$308,997
AOCI$339,860$331,727$269,362$267,734
Other Equity$0$0$6,317$6,317
Total Equity-$16,120$6,304$4,317$43,639
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$9,928$16,282$19,716$79,943
Net Debt$13,478-$5,946-$12,053-$41,216